3 withdrawn, 2 completed, 1 enrolling by invitation, 1 recruiting. 4 Not applicable, 1 Early Phase 1, 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 4 | Completed 2, Withdrawn 2 |
| Early Phase 1 | 1 | Unknown 1 |
| Phase 2 | 1 | Withdrawn 1 |
| Phase 4 | 1 | Terminated 1 |
Follow Pulmonary Embolism Subacute Massive: new trials by email Literature Review of Pulmonary Embolism Subacute Massive trials Research Report on Pulmonary Embolism Subacute Massive
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Multimodal Physiologic State Intelligence Study OMNIPHYS Multimodal Ultrasound Imaging System - Heart Failure, Cardiomyopathies | Enrolling by invitation | Truway Health, Inc. | 25000 | 2026-09-02 | 2026-09-10 | |
| Effect of iNO in Patients With Submassive and Massive PE inhaled nitric oxide (iNO) - Pulmonary Embolism, Pulmonary Embolism Subacute Massive | Phase 2 | Withdrawn | University of California, Los Angeles | 2026-06-01 | 2026-03-18 | |
| Non-Invasive Measurement of Cardiac Output and Stroke Volume in PE Non-invasive hemodynamic measurements - Pulmonary Embolism, Pulmonary Embolus/Emboli | Not applicable | Withdrawn | University of California, Los Angeles | 2025-07-15 | 2026-03-18 | |
| Artificial Intelligence to StrategiCally Enhance Pulmonary Embolism Response Team Activation Walking test - Pulmonary Embolism Subacute Massive | Not applicable | Withdrawn | University Hospitals Cleveland Medical Center | 2025-01-01 | 2025-01-23 | |
| Effect of Thrombolysis on 30-day Mortality in Intermediate High Risk Pulmonary Patients With Low Bleeding Risk Thrombolytic therapy for the study group in the form of streptokinase or recombinant tissue plasminogen activator, Unfractionated Heparin IV - Pulmonary Embolism Subacute Massive, Thrombolytic Therapy | Not applicable | Completed | Ain Shams University | 100 | 2023-07-01 | 2026-01-29 |
| Catheter Directed Therapy in Intermediate Risk Pulmonary Embolism Patients Mechanical embolectomy: by hydromechanical defragmentation by pigtail, Suction embolectomy by the Penumbra Indigo aspiration system - Pulmonary Embolism Subacute Massive | Early Phase 1 | Unknown | Assiut University | 200 | 2022-12-30 | 2022-11-10 |
| Cohort Study on Treatment Comes of Catheter-based Therapy in Patients With Acute Pulmonary Embolism in Hong Kong catheter-based therapy - Pulmonary Embolism Acute, Pulmonary Embolism Acute Massive | Recruiting | Chinese University of Hong Kong | 1000 | 2022-06-01 | 2025-06-19 | |
| Safe Delivery of Thrombolytic Treatment for Pulmonary Embolism Using ClotPro® Viscoelastic Tests Alteplase Injectable Product - Pulmonary Embolism Subacute Massive, Complication of Treatment | Not applicable | Completed | Semmelweis University | 33 | 2021-12-17 | 2024-10-31 |
| Standard-dose Apixaban AFtEr Very Low-dose ThromboLYSis for Acute Intermediate-high Risk Acute Pulmonary Embolism Alteplase, Unfractionated heparin, Placebo - Pulmonary Embolism With Acute Cor Pulmonale, Pulmonary Embolism | Phase 4 | Terminated | Victor Tapson, MD | 4 | 2019-07-25 | 2021-06-11 |
Pulmonary Embolism (4) · Heart Failure (2) · Acute Kidney Injury (1) · Aortic Diseases (1) · Cardiomyopathies (1) · Clinical Deterioration (1) · Disease (1) · Embolism (1) · Focal cortical dysplasia of Taylor (1) · Heart Valve Diseases (1) · Hemorrhage (1) · Hypertension (1) · Hypertension, Pulmonary (1) · Intracranial Aneurysm (1) · Lung Diseases (1)
Cardiovascular Diseases (4) · Embolism and Thrombosis (4) · Respiratory Tract Diseases (4) · Vascular Diseases (4) · Embolism (3) · Lung Diseases (3) · Heart Diseases (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Aneurysm (1) · Arterial Occlusive Diseases (1) · Arteriosclerosis (1) · Atherosclerosis (1) · Brain Diseases (1) · Central Nervous System Diseases (1)
Tissue Plasminogen Activator (2) · Endothelium-Dependent Relaxing Factors (1) · Heparin (1) · Thrombolytic Therapy (1) · apixaban (1)
University of California, Los Angeles (2) · Ain Shams University (1) · Assiut University (1) · Chinese University of Hong Kong (1) · Semmelweis University (1) · Truway Health, Inc. (1) · University Hospitals Cleveland Medical Center (1) · Victor Tapson, MD (1)
United States (5) · Egypt (1) · Hong Kong (1) · Hungary (1)
Aaron S Weinberg, MD (1) · Gavin C Solomon, M.D. (1) · Jun Li, MD (1) · Rajan Saggar, M.D. (1) · Richard N Channick, M.D. (1) · Shrouk K Ali, MSc (1) · Victor F Tapson, MD (1)
PMID 16432055, PMID 16598645, PMID 20696966, PMID 22005573, PMID 22494827, PMID 24917641, PMID 26791063, PMID 26961819, PMID 29070502, PMID 30633959, PMID 32243942, PMID 9407246